Covetrus Investor Relations Material

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. The company design, manufacture, and sell pharmaceutical products for use in treating various ailments in animals such as horses, dogs and cats. Covetrus Animal Health offers a range of products for animal health markets including United States, Canada, Mexico, Brazil, Argentina and Peru. The company's products include drug therapies for cardiovascular conditions; respiratory disorders; gastrointestinal disease; reproductive disorders; urinary tract diseases; infectious diseases; cancers of the skin and internal organs; dental diseases and hoof care; neurotoxicosis in cattle (lesions); toxicosis and mycotoxicoses in ruminants (vomitoxin); preanesthetic products; antibiotics for poultry; parasiticides and antiparasiticides products for livestock; endectocides for swine and other animals.